Hydromorphone hydrochloride injection (Dilaudid, Purdue) might be a viable treatment option for patients with long-term opioid addiction, a new study suggests.
A team of researchers from Canada conducted a Phase III, double-blind, noninferiority trial to compare injectable hydromorphone hydrochloride with diacetylmorphine hydrochloride for reducing illicit heroin use. Diacetylmorphine, the active ingredient of heroin, “is effective for the treatment of severe opioid use disorder”